Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients

Mokdad, 2001, The continuing epidemics of obesity and diabetes in the United States, JAMA, 286, 1195, 10.1001/jama.286.10.1195 Tooke, 2000, Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes, J. Diabet. Complications, 14, 197, 10.1016/S1056-8727(00)00083-0 Creager, 2003, Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I, Circulation, 108, 1527, 10.1161/01.CIR.0000091257.27563.32 Santilli, 2004, The role of nitric oxide in the development of diabetic angiopathy, Horm. Metab. Res., 36, 319, 10.1055/s-2004-814489 Ignarro, 1987, Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide, Proc. Natl. Acad. Sci. USA, 84, 9265, 10.1073/pnas.84.24.9265 Palmer, 1987, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, 524, 10.1038/327524a0 Cooke, 1997, Nitric oxide synthase: role in the genesis of vascular disease, Annu. Rev. Med., 48, 489, 10.1146/annurev.med.48.1.489 Metzger, 2005, Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men, Pharmacogenet. Genomics, 15, 565, 10.1097/01.fpc.0000167328.85163.44 Hingorani, 2001, Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000, Atherosclerosis, 154, 521, 10.1016/S0021-9150(00)00699-7 Tanus-Santos, 2001, Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants, Pharmacogenetics, 11, 719, 10.1097/00008571-200111000-00011 Taverna, 2002, eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy, Diabet. Med., 19, 240, 10.1046/j.1464-5491.2002.00681.x Taverna, 2005, The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy, Nitric Oxide, 13, 88, 10.1016/j.niox.2005.04.004 Frost, 2003, Endothelial nitric oxide synthase (ecNOS) 4 a/b gene polymorphism and carotid artery intima-media thickness in type-1 diabetic patients, Exp. Clin. Endocrinol. Diabetes, 111, 12, 10.1055/s-2003-37494 Neugebauer, 2000, Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes, Diabetes, 49, 500, 10.2337/diabetes.49.3.500 Awata, 2004, Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes, Diabetes Care, 27, 2184, 10.2337/diacare.27.9.2184 Powers, 2001, Diabetes mellitus, Harrison’s Princ. Intern. Med., 333, 2109 Tooke, 1999, Vascular function in type 2 diabetes mellitus and pre-diabetes: the case for intrinsic endotheiopathy, Diabet. Med., 16, 710, 10.1046/j.1464-5491.1999.00099.x Taverna, 2004, Genetics of diabetic complications: retinopathy, Ann. Endocrinol. (Paris), 65, S17, 10.1016/S0003-4266(04)95997-5 Cai, 1998, A common Glu298–>Asp (894G–>T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes, Diabetes Care, 21, 2195, 10.2337/diacare.21.12.2195 Crawford, 2005, Definition and clinical importance of haplotypes, Annu. Rev. Med., 56, 303, 10.1146/annurev.med.56.082103.104540 Johnson, 2001, Haplotype tagging for the identification of common disease genes, Nat. Genet., 29, 233, 10.1038/ng1001-233 Tanus-Santos, 2002, Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol, Pharmacogenetics, 12, 407, 10.1097/00008571-200207000-00008 Nagassaki, 2005, eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population, Thromb. Res., 115, 375, 10.1016/j.thromres.2004.09.003 Marroni, 2005, Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase (eNOS) genetic polymorphisms, Nitric Oxide, 12, 177, 10.1016/j.niox.2005.02.002 V.C. Sandrim, E.B. Coelho, F. Nobre, G.M. Arado, V.L. Lanchote, J.E. Tanus-Santos, Susceptible and protective eNOS haplotypes in hypertensive black and white subjects, Atherosclerosis (2006) in Press. Franks, 2005, Variation in the eNOS gene modifies the association between total energy expenditure and glucose intolerance, Diabetes, 54, 2795, 10.2337/diabetes.54.9.2795 Wang, 2002, Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking, Arterioscler Thromb. Vasc. Biol., 22, e1, 10.1161/01.ATV.0000016248.51577.1F